Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;17(1):143-154.
doi: 10.2215/CJN.04230321. Epub 2021 Dec 20.

Guidelines for Genetic Testing and Management of Alport Syndrome

Affiliations

Guidelines for Genetic Testing and Management of Alport Syndrome

Judy Savige et al. Clin J Am Soc Nephrol. 2022 Jan.

Erratum in

Abstract

Genetic testing for pathogenic COL4A3-5 variants is usually undertaken to investigate the cause of persistent hematuria, especially with a family history of hematuria or kidney function impairment. Alport syndrome experts now advocate genetic testing for persistent hematuria, even when a heterozygous pathogenic COL4A3 or COL4A4 is suspected, and cascade testing of their first-degree family members because of their risk of impaired kidney function. The experts recommend too that COL4A3 or COL4A4 heterozygotes do not act as kidney donors. Testing for variants in the COL4A3-COL4A5 genes should also be performed for persistent proteinuria and steroid-resistant nephrotic syndrome due to suspected inherited FSGS and for familial IgA glomerulonephritis and kidney failure of unknown cause.

Keywords: Alport syndrome; COL4A3; COL4A4; COL4A5; FSGS; collagen IV; digenic Alport syndrome; genetic testing; kidney cysts; thin basement membrane nephropathy.

PubMed Disclaimer

References

    1. Grunfeld JP: Hereditary renal diseases. Saudi J Kidney Dis Transpl 8: 227–234, 1997 - PubMed
    1. Savige J, Rana K, Tonna S, Buzza M, Dagher H, Wang YY: Thin basement membrane nephropathy. Kidney Int 64: 1169–1178, 2003 - PubMed
    1. Gibson J, Fieldhouse R, Chan MM, Sadeghi-Alavijeh O, Burnett L, Izzi V, Persikov AV, Gale DP, Storey H, Savige J: Prevalence estimates of predicted pathogenic COL4A3–COL4A5 variants in a population sequencing database and their implications for alport syndrome. J Am Soc Nephrol 32: 2273–2290, 2021 - PMC - PubMed
    1. Gubler M, Levy M, Broyer M, Naizot C, Gonzales G, Perrin D, Habib R: Alport’s syndrome. A report of 58 cases and a review of the literature. Am J Med 70: 493–505, 1981 - PubMed
    1. Feingold J, Bois E, Chompret A, Broyer M, Gubler MC, Grünfeld JP: Genetic heterogeneity of Alport syndrome. Kidney Int 27: 672–677, 1985 - PubMed

Publication types

MeSH terms